KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Total Non-Current Liabilities (2016 - 2025)

Astrana Health (ASTH) has disclosed Total Non-Current Liabilities for 14 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 119.96% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, up 119.96% year-over-year, with the annual reading at $1.0 billion for FY2025, 119.96% up from the prior year.
  • Total Non-Current Liabilities hit $1.0 billion in Q4 2025 for Astrana Health, down from $1.1 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.1 billion in Q3 2025 to a low of $230.4 million in Q2 2021.
  • Historically, Total Non-Current Liabilities has averaged $393.7 million across 5 years, with a median of $261.0 million in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: dropped 12.04% in 2021 and later surged 126.19% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $242.0 million in 2021, then increased by 7.05% to $259.1 million in 2022, then grew by 17.32% to $303.9 million in 2023, then soared by 56.33% to $475.1 million in 2024, then soared by 119.96% to $1.0 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for ASTH at $1.0 billion in Q4 2025, $1.1 billion in Q3 2025, and $444.7 million in Q2 2025.